Viatris Statement on the Close of the Active Pharmaceutical Ingredients Business Divestiture

June 3, 2024 at 9:00 AM EDT

PITTSBURGH, June 3, 2024 – Viatris Inc. announced today the closing of the previously disclosed transaction to divest its Active Pharmaceutical Ingredients (API) Business in India to Matrix Pharma Private Limited.  Please refer to Viatris’ Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, filed with the United States Securities and Exchange Commission, for more information regarding the transaction.

About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life’s moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India.  Learn more at and, and connect with us on LinkedIn, Instagram, YouTube and X (formerly Twitter).
MEDIA                                                                           INVESTORS

+1.724.514.1968                                                        Bill Szablewski                               +1.412.707.2866

Jennifer Mauer                                                 

Matt Klein

# # #